Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level disease » severe disease (Expand Search), vessel disease (Expand Search), lethal disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level disease » severe disease (Expand Search), vessel disease (Expand Search), lethal disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
20681
Data Sheet 1_Assessing cross-national inequalities and predictive trends in gout burden: a global perspective (1990–2021).pdf
Published 2025“…Advanced analysis indicated substantial gaps between observed gout burden and optimal levels in high-SDI countries, such as the United States and Australia, highlighting unrealized opportunities for improving outcomes. …”
-
20682
-
20683
-
20684
Table 6_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx
Published 2025“…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
-
20685
Table 4_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx
Published 2025“…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
-
20686
Table 5_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx
Published 2025“…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
-
20687
Table 3_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx
Published 2025“…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
-
20688
Table 7_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx
Published 2025“…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
-
20689
Table 2_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xls
Published 2025“…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
-
20690
Image 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.tif
Published 2025“…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
-
20691
Table 1_Global burden of low back pain attributable to smoking in 204 countries and territories in 1990–2021.xlsx
Published 2025“…It uses data from the 2021 Global Burden of Disease (GBD), providing scientific evidence for policy-making.…”
-
20692
-
20693
Data Sheet 1_Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated...
Published 2024“…Introduction<p>Ovarian cancer is a lethal disease with low survival rates for women diagnosed in advanced stages. …”
-
20694
-
20695
-
20696
DataSheet1_Exploring lipodystrophy gene expression in adipocytes: unveiling insights into the pathogenesis of insulin resistance, type 2 diabetes, and clustering diseases (metaboli...
Published 2024“…Background<p>Studying the molecular mechanisms of lipodystrophy can provide valuable insights into the pathophysiology of insulin resistance (IR), type 2 diabetes (T2D), and other clustering diseases [metabolic syndrome (MetS)] and its underlying adipocentric disease (MetS disease).…”
-
20697
IgE Guided Use of ICS in Patients with Stable COPD: A Real-World Observational Study
Published 2025“…</p> <p>The total serum IgE level is closely related to exacerbations of COPD. …”
-
20698
Table 3_The CATALYTIC tool to assess feasibility of implementing evidence-based interventions for cardiovascular diseases in 46 low- and middle-income countries: survey outcomes an...
Published 2025“…Background<p>Evidence-based interventions (EBI) for cardiovascular disease (CVD) in low- and middle-income countries (LMIC) may face feasibility challenges due to the inadequacy of existing instruments. …”
-
20699
Table 5_The CATALYTIC tool to assess feasibility of implementing evidence-based interventions for cardiovascular diseases in 46 low- and middle-income countries: survey outcomes an...
Published 2025“…Background<p>Evidence-based interventions (EBI) for cardiovascular disease (CVD) in low- and middle-income countries (LMIC) may face feasibility challenges due to the inadequacy of existing instruments. …”
-
20700
Table 1_The CATALYTIC tool to assess feasibility of implementing evidence-based interventions for cardiovascular diseases in 46 low- and middle-income countries: survey outcomes an...
Published 2025“…Background<p>Evidence-based interventions (EBI) for cardiovascular disease (CVD) in low- and middle-income countries (LMIC) may face feasibility challenges due to the inadequacy of existing instruments. …”